Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

TCT 2017: Rich in Clinical Trials, Star Power

Published: Tue, 17 Oct 2017 10:58:42 EDT
Oscar-winner Tom Hanks headlines a conference that will feature clinical trials looking at management of left main disease, cardiogenic shock, and bioabsorbable scaffolds.
Medscape Medical News

PFO Closure Reduces Strokes, and PPIs Increase Dementia Risk?

Published: Tue, 17 Oct 2017 10:24:56 EDT
New research suggests that reducing patent foramen ovale size could lessen stroke risk, while other work explores the role that PPIs might play in causing dementia.
Medscape Neurology

How Much Is Your Practice Worth?

Published: Tue, 17 Oct 2017 10:00:00 EDT
Many doctors who have a financial stake in a practice don't know what the practice is worth. That's a mistake, say experts in practice valuation. Here's why, and what a practice valuation involves.
Medscape Business of Medicine

Ophthalmologists Spend Substantial Time on EHR Use

Published: Tue, 17 Oct 2017 08:37:18 EDT
Ophthalmologists spent more than three and a half hours per clinical day using EHRs, although billing levels and clinic volume led to variations in EHR use among physicians, a study has found.
Medscape Medical News
Displaying results 9-12 (of 20)
 1 - 2 - 3 - 4 - 5 


Roche taps Warp Drive to discover novel antibiotic classes in $387M pact

Published: Mon, 16 Oct 2017 08:17:25 +0000
Roche has teamed up with Warp Drive Bio to access novel classes of antibiotics. The Big Pharma will pay up to $387 million to license and advance certain classes from the more than 100 groups of possibly novel antibiotics Warp Drive is analyzing.

Revamped CAR-T could curb HIV levels without antiretroviral drugs

Published: Fri, 13 Oct 2017 20:32:11 +0000
A new CAR-T approach controlled HIV spread and protected T cells from being attacked by HIV in mouse models that had been taken off antiretroviral treatment.

InflaRx snags $55M for inflammatory, autoimmune trials

Published: Fri, 13 Oct 2017 12:56:18 +0000
InflaRx has raised $55 million (€47 million) in a new funding round. The series D follows fast after InflaRx established the potential of its anti-human complement factor C5a monoclonal antibody IFX-1 with phase 2a data. 

NIH public-private PACT aims to fire the Cancer Moonshot boosters

Published: Fri, 13 Oct 2017 12:13:34 +0000
The National Institutes of Health (NIH) has enlisted the help of 11 top-tier biopharma companies as it pushes towards the goal of cutting the time it takes to bring new cancer immunotherapies to patients in half.
Displaying results 9-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy